此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

GREENWATER 2.0: Reducing Iodinated Contrast Agents in Hospital Wastewater (GREENWATER 2)

2026年6月19日 更新者:I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

GREENWATER 2.0: Cutting Edge Solution for Reducing Iodinated Contrast Agents Via Post-Administration Collection Device

The goal of this observational study is to learn if using a dedicated urine collection device after CT scans can help reduce the amount of iodinated contrast agent released into hospital wastewater in adult outpatients undergoing contrast-enhanced CT scans.

The main questions it aims to answer are:

  • Does the dedicated urine collection device improve patient acceptance and compliance with post-contrast urine collection?
  • How much iodinated contrast agent can be recovered from urine collected after CT scans?

Participants will:

  • Have their planned CT scan with iodinated contrast agent as part of their regular medical care.
  • Wait in the radiology department for about 60 minutes after the contrast injection.
  • Use a dedicated urine collection device before leaving the hospital.
  • Answer short questions about their experience with the device.

This does not change the CT scan, the contrast agent used, or the standard clinical imaging procedure. The only additional procedure is the use of the dedicated urine collection device after the scan.

研究概览

详细说明

GREENWATER 2.0 is a single-center, prospective observational study with an additional urine collection procedure. The study will be conducted in the diagnostic imaging department of IRCCS Ospedale Galeazzi - Sant'Ambrogio and will include adult outpatients undergoing clinically indicated contrast-enhanced CT scans with iodinated contrast agents.

Iodinated contrast agents are widely used in CT imaging to improve diagnostic accuracy. After intravenous administration, these agents are predominantly eliminated unchanged through urine. Because conventional wastewater treatment may not fully remove iodinated contrast agent residues, urine collection shortly after contrast administration may represent a practical strategy to reduce their release into hospital wastewater.

The study builds on the previous GREENWATER study, which showed high patient willingness to participate in a sustainability-focused urine collection protocol after contrast-enhanced imaging. In GREENWATER 2.0, a dedicated urine collection device will be installed in the radiology department to make the collection process more practical and integrated into the clinical workflow.

Participants will undergo their scheduled CT scan according to standard clinical practice. The indication for the CT scan, the choice of iodinated contrast agent, the contrast dose, and the imaging protocol will not be modified for research purposes. After contrast injection, participants will be asked to remain in the radiology department for about 60 minutes and then use the dedicated urine collection device before leaving the hospital.

The study will evaluate whether this workflow is acceptable and feasible for patients in routine radiology practice. It will also assess the potential recovery of iodinated contrast agent residues from the collected urine. Additional information will be collected on the contrast agent administered, the volume of urine collected, the time between CT examination and device use, and patient-reported experience with the device, including comfort, ease of use, cleanliness, privacy, odor, waiting time perception, and clarity of instructions.

The study is expected to provide evidence on the feasibility of using a dedicated urine collection device in a hospital radiology department as a sustainability measure to reduce the environmental impact of iodinated contrast agents. The planned sample size is 416 participants, with recruitment expected to last approximately 12 months. The total study duration is expected to be approximately 18 months, including recruitment, data analysis, and preparation of the final study report.

研究类型

观察性的

注册 (估计的)

416

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Luca Maria Sconfienza, MD, PhD
  • 电话号码:+390283502227
  • 邮箱:io@lucasconfienza.it

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

取样方法

非概率样本

研究人群

Adult outpatients aged 18 years or older undergoing clinically indicated contrast-enhanced CT scans with iodinated contrast agents at IRCCS Ospedale Galeazzi - Sant'Ambrogio. Participants will receive standard clinical care, with no modification to the CT protocol or contrast administration. The only study-specific procedure is the post-contrast use of a dedicated urine collection device after an approximately 60-minute waiting period.

描述

Inclusion Criteria:

  • Adult patients aged 18 years or older.
  • Patients scheduled for a clinically indicated contrast-enhanced CT scan with iodinated contrast agent.
  • Patients able to provide written informed consent.
  • Patients willing to wait approximately 60 minutes after contrast injection before using the dedicated urine collection device.

Exclusion Criteria:

- Patients unable to use the dedicated urine collection device for urine collection.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Adult Outpatients Undergoing Contrast-Enhanced CT
Adult outpatients scheduled for clinically indicated contrast-enhanced CT scans with iodinated contrast agents. Participants will undergo their standard CT examination with no change to the imaging protocol or contrast administration. After contrast injection, they will be asked to wait approximately 60 minutes in the radiology department and then use a dedicated urine collection device before leaving the hospital.
A dedicated urine collection device installed in the radiology department for use after contrast-enhanced CT scans. Participants will undergo their CT scan according to standard clinical practice, with no change to the imaging protocol, contrast agent selection, or contrast administration. After iodinated contrast injection, participants will be asked to wait approximately 60 minutes and then use the dedicated device before leaving the hospital. The collected urine will be used to assess the potential recovery of iodinated contrast agent residues and the feasibility of this workflow in routine radiology practice.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Patient Acceptance and Compliance With Post-Contrast Urine Collection
大体时间:At the time of the CT examination, up to 60 minutes after contrast injection
Proportion of eligible participants who agree to participate in the study and complete the post-contrast urine collection procedure using the dedicated urine collection device after contrast-enhanced CT.
At the time of the CT examination, up to 60 minutes after contrast injection

次要结果测量

结果测量
措施说明
大体时间
Potential Recovery of Iodinated Contrast Agent From Collected Urine
大体时间:At the time of the CT examination, up to 60 minutes after contrast injection
Amount or proportion of iodinated contrast agent recovered from urine collected using the dedicated urine collection device after contrast-enhanced CT, based on the administered contrast agent and urine analysis.
At the time of the CT examination, up to 60 minutes after contrast injection

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年3月10日

初级完成 (估计的)

2026年9月1日

研究完成 (估计的)

2026年12月1日

研究注册日期

首次提交

2026年5月27日

首先提交符合 QC 标准的

2026年5月27日

首次发布 (实际的)

2026年6月2日

研究记录更新

最后更新发布 (实际的)

2026年6月24日

上次提交的符合 QC 标准的更新

2026年6月19日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅